DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sobrero AF. et al.
FOLFOX4/XELOX in stage II–III colon cancer: Efficacy results of the Italian three or six colon adjuvant (TOSCA) trial.
J Clin Oncol 2017
35. (suppl; abstr 3501)
We do not assume any responsibility for the contents of the web pages of other providers.